MDXG FY 2023 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$321M+20.0% YoY

Gross Profit

$267M83.0% margin

Operating Income

$37M11.5% margin

Net Income

$67M21.0% margin

EPS (Diluted)

$0.38

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$25M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$239M

Total Liabilities

$96M

Stockholders' Equity

$143M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$321M	$268M	+20.0%
Gross Profit	$267M	$220M	+21.6%
Operating Income	$37M	-$15M	+352.0%
Net Income	$67M	-$30M	+323.3%